---
title: "Insmed Announces Positive Topline Results from Phase 3b ENCORE Study of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with MAC Lung Disease | INSM Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280147174.md"
description: "Insmed Announces Positive Topline Results from Phase 3b ENCORE Study of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with MAC Lung Disease | INSM Stock News"
datetime: "2026-03-23T03:00:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280147174.md)
  - [en](https://longbridge.com/en/news/280147174.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280147174.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/280147174.md) | [繁體中文](https://longbridge.com/zh-HK/news/280147174.md)


# Insmed Announces Positive Topline Results from Phase 3b ENCORE Study of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with MAC Lung Disease | INSM Stock News

Insmed Announces Positive Topline Results from Phase 3b ENCORE Study of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with MAC Lung Disease | INSM Stock News

### Related Stocks

- [ARK Genomic Revolution ETF (ARKG.US)](https://longbridge.com/en/quote/ARKG.US.md)
- [ALPS Medical Breakthroughs ETF (SBIO.US)](https://longbridge.com/en/quote/SBIO.US.md)
- [State Street® SPDR® S&P® Biotech ETF (XBI.US)](https://longbridge.com/en/quote/XBI.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/en/quote/IBB.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/en/quote/BBH.US.md)
- [Invesco Dorsey Wright Healthcare MomtETF (PTH.US)](https://longbridge.com/en/quote/PTH.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/en/quote/PBE.US.md)
- [Direxion Daily S&P Biotech Bull 3X ETF (LABU.US)](https://longbridge.com/en/quote/LABU.US.md)
- [Insmed Incorporated (INSM.US)](https://longbridge.com/en/quote/INSM.US.md)
- [First Trust NYSE Arca Biotech ETF (FBT.US)](https://longbridge.com/en/quote/FBT.US.md)

## Related News & Research

- [Insmed Sees Rising Physician Adoption of Brinsupri, Morgan Stanley Says](https://longbridge.com/en/news/281049788.md)
- [Nordea Investment Management AB Makes New Investment in Insmed, Inc. $INSM](https://longbridge.com/en/news/280871422.md)
- [Insmed (INSM): ENCORE Phase 3 Success Expands MAC Lung Disease Opportunity and Underscores Arikayce Upside](https://longbridge.com/en/news/280194631.md)
- [Insmed Maps Aggressive 2026 As Newly Approved Lung Disease Drug Gains Traction, Pipeline Advances](https://longbridge.com/en/news/272101100.md)
- [Insmed Lung Infection Therapy Data Impresses, Analyst Sees Approval Path](https://longbridge.com/en/news/280195463.md)